Type 2 diabetes–associated variants of the MT 2 melatonin receptor affect distinct modes of signaling
Abstract
function during the day, when melatonin is undetectable, but spontaneous activity of the receptor occurs.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Other studies show that elevated melatonin concentrations are associated with impaired glucose control.
“others show associations with impaired glucose control (18)(19)(20).”
From Interplay of Dinner Timing and <i>MTNR1B</i> Type 2 Diabetes Risk Variant on Glucose Tolerance and Insulin Secretion: A Randomized Crossover Trial (2022) · cites this paper as [19]
Cites
Standards of Medical Care in Diabetes
Power, D. V. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1593 · Cited by 8,672 · see citing works
Standards of medical care in diabetes—2014
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc14-s014 · Cited by 4,572 · see citing works
Circadian integration of metabolism and energetics
Bass, J., & Takahashi, J. S. (2010) · Science · doi:10.1126/science.1195027 · Cited by 1,910 · see citing works
Single-Cell Transcriptome Profiling of Human Pancreatic Islets in Health and Type 2 Diabetes
Segerstolpe, Å., Palasantza, A., Eliasson, P., Andersson, E.-M., Andréasson, A.-C., Sun, X., Picelli, S., Sabirsh, A., Clausen, M., Bjursell, M. K., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.08.020 · Cited by 1,550 · see citing works
Disruption of the clock components CLOCK and BMAL1 leads to hypoinsulinaemia and diabetes
Marcheva, B., Ramsey, K. M., Buhr, E. D., Kobayashi, Y., Su, H., Ko, C. H., Ivanova, G., Omura, C., Mo, S., Vitaterna, M. H., et al. (2010) · Nature · doi:10.1038/nature09253 · Cited by 1,525 · see citing works
An Evolutionary Trace Method Defines Binding Surfaces Common to Protein Families
Lichtarge, O., Bourne, H. R., & Cohen, F. E. (1996) · Journal of Molecular Biology · doi:10.1006/jmbi.1996.0167 · Cited by 1,196 · see citing works
Operational models of pharmacological agonism
Black, J. W., & Leff, P. (1983) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.1983.0093 · Cited by 1,111 · see citing works
The genetic architecture of type 2 diabetes
Fuchsberger, C., Flannick, J., Teslovich, T. M., Mahajan, A., Agarwala, V., Gaulton, K. J., Ma, C., Fontanillas, P., Moutsianas, L., McCarthy, D. J., et al. (2016) · Nature · doi:10.1038/nature18642 · Cited by 1,051 · see citing works
DESENSITIZATION OF G PROTEIN–COUPLED RECEPTORS AND NEURONAL FUNCTIONS
Gainetdinov, R. R., Premont, R. T., Bohn, L., Lefkowitz, R. J., & Caron, M. G. (2004) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.27.070203.144206 · Cited by 864 · see citing works
Teaching old receptors new tricks: biasing seven-transmembrane receptors
Rajagopal, S., Rajagopal, K., & Lefkowitz, R. J. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3024 · Cited by 826 · see citing works
Lyssenko, V., Nagorny, C. L. F., Erdos, M. R., Wierup, N., Jonsson, A., Spégel, P., Bugliani, M., Saxena, R., Fex, M., Pulizzi, N., et al. (2009) · Nature Genetics · doi:10.1038/ng.288 · Cited by 742 · see citing works
Signalling bias in new drug discovery: detection, quantification and therapeutic impact
Kenakin, T., & Christopoulos, A. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3954 · Cited by 741 · see citing works
Melatonin membrane receptors in peripheral tissues: Distribution and functions
Slominski, R. M., Reiter, R. J., Schlabritz‐Loutsevitch, N., Ostrom, R. S., & Slominski, A. T. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.01.004 · Cited by 676 · see citing works
An abundance of rare functional variants in 202 drug target genes sequenced in 14,002 people
Nelson, M. R., Wegmann, D., Ehm, M. G., Kessner, D., St. Jean, P., Verzilli, C., Shen, J., Tang, Z., Bacanu, S.-A., Fraser, D., et al. (2012) · Science · doi:10.1126/science.1217876 · Cited by 647 · see citing works
Dubocovich, M. L., Delagrange, P., Krause, D. N., Sugden, D., Cardinali, D. P., & Olcese, J. (2010) · Pharmacological Reviews · doi:10.1124/pr.110.002832 · Cited by 636 · see citing works
GPCR-G Protein-β-Arrestin Super-Complex Mediates Sustained G Protein Signaling
Thomsen, A. R. B., Plouffe, B., Cahill, T. J., Shukla, A. K., Tarrasch, J. T., Dosey, A. M., Kahsai, A. W., Strachan, R. T., Pani, B., Mahoney, J. P., et al. (2016) · Cell · doi:10.1016/j.cell.2016.07.004 · Cited by 563 · see citing works
A Simple Method for Quantifying Functional Selectivity and Agonist Bias
Kenakin, T., Watson, C., Muniz-Medina, V. M., Christopoulos, A., & Novick, S. J. (2011) · ACS Chemical Neuroscience · doi:10.1021/cn200111m · Cited by 488 · see citing works
Fadista, J., Vikman, P. J., Ottosson-Laakso, E., Mollet, I. G., Esguerra, J. L. S., Taneera, J., Storm, P., Osmark, P., Ladenvall, C., Prasad, R. B., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1402665111 · Cited by 470 · see citing works
Update on melatonin receptors: IUPHAR Review 20
Jockers, R., Delagrange, P., Dubocovich, M. L., Markus, R. P., Renault, N., Tosini, G., Cecon, E., & Zlotos, D. P. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13536 · Cited by 426 · see citing works
Islet G protein-coupled receptors as potential targets for treatment of type 2 diabetes
Åhrén, B. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2782 · Cited by 417 · see citing works
Gaulton, K. J., Ferreira, T. C., Lee, Y., Raimondo, A., Mägi, R., Reschen, M. E., Mahajan, A., Locke, A. E., Rayner, N. W., Robertson, N., et al. (2015) · Nature Genetics · doi:10.1038/ng.3437 · Cited by 390 · see citing works
Melatonin secretion and the incidence of type 2 diabetes
McMullan, C. J., Schernhammer, E. S., Rimm, E. B., Hu, F. B., & Forman, J. P. (2013) · JAMA · doi:10.1001/jama.2013.2710 · Cited by 369 · see citing works
The evasive nature of drug efficacy: implications for drug discovery
Galandrin, S., Oligny-Longpré, G., & Bouvier, M. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.06.005 · Cited by 364 · see citing works
Rare MTNR1B variants impairing melatonin receptor 1B function contribute to type 2 diabetes
The Meta-Analysis of Glucose and Insulin-Related Traits Consortium (MAGIC), Bonnefond, A., Clément, N., Fawcett, K., Yengo, L., Vaillant, E., Guillaume, J.-L., Dechaume, A., Payne, F., Roussel, R., et al. (2012) · Nature Genetics · doi:10.1038/ng.1053 · Cited by 363 · see citing works
Blodgett, D. M., Nowosielska, A., Afik, S., Pechhold, S., Cura, A. J., Kennedy, N. J., Kim, S., Kucukural, A., Davis, R. J., Kent, S. C., et al. (2015) · Diabetes · doi:10.2337/db15-0039 · Cited by 330 · see citing works
Ayoub, M. A., Couturier, C., Lucas-Meunier, E., Angers, S., Fossier, P., Bouvier, M., & Jockers, R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200729200 · Cited by 322 · see citing works
Melatonin receptors, heterodimerization, signal transduction and binding sites: what's new?
Jockers, R., Maurice, P., Boutin, J. A., & Delagrange, P. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.184 · Cited by 293 · see citing works
Self-citationGz, a guanine nucleotide-binding protein with unique biochemical properties.
Casey, P. J., Fong, H. K. W., Simon, M. I., & Gilman, A. G. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)39988-0 · Cited by 291 · see citing works
Melatonin receptors: molecular pharmacology and signalling in the context of system bias
Cecon, E., Oishi, A., & Jockers, R. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13950 · Cited by 286 · see citing works
Signaling by internalized G-protein-coupled receptors
Calebiro, D., Nikolaev, V. O., Persani, L., & Lohse, M. J. (2010) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2010.02.002 · Cited by 266 · see citing works
Increased melatonin signaling is a risk factor for type 2 diabetes
Tuomi, T., Nagorny, C. L. F., Singh, P., Bennet, H., Yu, Q., Alenkvist, I., Isomaa, B., Östman, B., Söderström, J., Pesonen, A.-K., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.04.009 · Cited by 262 · cited 1× · see citing works
“Functional studies on the common SNP rs10830963, located in the intron of MTNR1B, showed a twofold increase in MTNR1B mRNA abundance in human pancreatic islets of GG T2D risk allele carriers (9).”
BackgroundLiu, D. J., & Leal, S. M. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1001156 · Cited by 236 · see citing works
van der Westhuizen, E. T., Breton, B., Christopoulos, A., & Bouvier, M. (2013) · Molecular Pharmacology · doi:10.1124/mol.113.088880 · Cited by 226 · see citing works
Endosomal generation of cAMP in GPCR signaling
Vilardaga, J., Jean‐Alphonse, F., & Gardella, T. J. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1611 · Cited by 209 · see citing works
Function and expression of melatonin receptors on human pancreatic islets
Ramracheya, R. D., Muller, D. S., Squires, P. E., Brereton, H., Sugden, D., Huang, G. C., Amiel, S. A., Jones, P. M., & Persaud, S. J. (2008) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2007.00523.x · Cited by 186 · see citing works
Melatonin, circadian rhythms, and sleep
Arendt, J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200010123431510 · Cited by 179 · see citing works
Shift work and diabetes – A systematic review
Knutsson, A., & Kempe, A. (2014) · Chronobiology International · doi:10.3109/07420528.2014.957308 · Cited by 178 · see citing works
van de Bunt, M., Fox, J. E. M., Dai, X.-Q., Barrett, A., Grey, C. L., Li, L., Bennett, A. J., Johnson, P. R. V., Rajotte, R. V., Gaulton, K. J., et al. (2015) · PLoS Genetics · doi:10.1371/journal.pgen.1005694 · Cited by 174 · see citing works
Melatonin and Pancreatic Islets: Interrelationships between Melatonin, Insulin and Glucagon
Peschke, E., Bähr, I., & Mühlbauer, E. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14046981 · Cited by 167 · see citing works
G protein-coupled receptors: mutations and endocrine diseases
Vassart, G., & Costagliola, S. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.20 · Cited by 164 · see citing works
Rare and Common Genetic Events in Type 2 Diabetes: What Should Biologists Know?
Bonnefond, A., & Froguel, P. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2014.12.020 · Cited by 163 · see citing works
Melatonin and type 2 diabetes – a possible link?*
Peschke, E., Stumpf, I., Bazwinsky, I., Litvak, L., Dralle, H., & Mühlbauer, E. (2007) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2007.00426.x · Cited by 161 · see citing works
G Protein-coupled Receptor (GPCR) Signaling via Heterotrimeric G Proteins from Endosomes
Tsvetanova, N. G., Irannejad, R., & von Zastrow, M. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.r114.617951 · Cited by 153 · see citing works
Heteromeric MT 1 /MT 2 Melatonin Receptors Modulate Photoreceptor Function
Baba, K., Benleulmi‐Chaachoua, A., Journé, A., Kamal, M. T., Guillaume, J., Dussaud, S., Gbahou, F., Yettou, K., Liu, C., Contreras‐Alcantara, S., et al. (2013) · Science Signaling · doi:10.1126/scisignal.2004302 · Cited by 145 · see citing works
Katsonis, P., & Lichtarge, O. (2014) · Genome Research · doi:10.1101/gr.176214.114 · Cited by 137 · see citing works
Self-citationTosini, G., Owino, S., Guillaume, J., & Jockers, R. (2014) · BioEssays · doi:10.1002/bies.201400017 · Cited by 132 · see citing works
Convergence of Melatonin and Serotonin (5-HT) Signaling at MT2/5-HT2C Receptor Heteromers
Kamal, M. T., Gbahou, F., Guillaume, J., Daulat, A. M., Benleulmi‐Chaachoua, A., Luka, M., Chen, P. B., Anaraki, D. K., Baroncini, M., la Cour, C. M., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.559542 · Cited by 128 · see citing works
Experimental and clinical aspects of melatonin and clock genes in diabetes
Peschke, E., Bähr, I., & Mühlbauer, E. (2015) · Journal of Pineal Research · doi:10.1111/jpi.12240 · Cited by 112 · see citing works
G protein-coupled receptors as targets for anti-diabetic therapeutics
Oh, D. Y., & Olefsky, J. M. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2015.4 · Cited by 110 · see citing works
Impact of Common Diabetes Risk Variant in MTNR1B on Sleep, Circadian, and Melatonin Physiology
Lane, J. M., Chang, A., Bjonnes, A., Aeschbach, D., Anderson, C., Cade, B. E., Cain, S. W., Czeisler, C. A., Gharib, S. A., Gooley, J. J., et al. (2016) · Diabetes · doi:10.2337/db15-0999 · Cited by 95 · see citing works
René, P., Gouill, C. L., Pogozheva, I. D., Lee, G., Mosberg, H. I., Farooqi, I. S., Valenzano, K. J., & Bouvier, M. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.172098 · Cited by 87 · see citing works
Systematic Functional Characterization of Candidate Causal Genes for Type 2 Diabetes Risk Variants
Thomsen, S. K., Ceroni, A., van de Bunt, M., Burrows, C., Barrett, A., Scharfmann, R., Ebner, D. V., McCarthy, M. I., & Gloyn, A. L. (2016) · Diabetes · doi:10.2337/db16-0361 · Cited by 86 · see citing works
Activation of melatonin signaling promotes β-cell survival and function
Costes, S., Boss, M., Thomas, A. P., & Matveyenko, A. V. (2015) · Molecular Endocrinology · doi:10.1210/me.2014-1293 · Cited by 84 · see citing works
Novel localization of a G protein, Gz-alpha, in neurons of brain and retina
Hinton, D., Blanks, J. C., Fong, H., Casey, P. J., Hildebrandt, E., & Simons, M. (1990) · Journal of Neuroscience · doi:10.1523/jneurosci.10-08-02763.1990 · Cited by 76 · see citing works
Hamdan, F. F., Rochdi, M. D., Breton, B., Fessart, D., Michaud, D. E., Charest, P. G., Laporte, S. A., & Bouvier, M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700577200 · Cited by 76 · see citing works
Feng, N. Y., & Bass, A. H. (2016) · Current Biology · doi:10.1016/j.cub.2016.07.079 · Cited by 74 · see citing works
McDermott, D. H., Lopez, J., Deng, F. M., Liu, Q., Ojode, T., Chen, H., Ulrick, J., Kwatemaa, N., Kelly, C., Anaya‐O’Brien, S., et al. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01210.x · Cited by 70 · see citing works
Armando, S., Quoyer, J., Lukashova, V., Maïga, A., Percherancier, Y., Heveker, N., Pin, J., Prézeau, L., & Bouvier, M. (2014) · The FASEB Journal · doi:10.1096/fj.13-242446 · Cited by 63 · see citing works
Karamitri, A., Renault, N., Clément, N., Guillaume, J., & Jockers, R. (2013) · Molecular Endocrinology · doi:10.1210/me.2013-1101 · Cited by 61 · see citing works
The vital role of constitutive GPCR activity in the mesolimbic dopamine system
Meye, F. J., Ramakers, G. M. J., & Adan, R. A. H. (2014) · Translational Psychiatry · doi:10.1038/tp.2013.130 · Cited by 55 · see citing works
Gαz Negatively Regulates Insulin Secretion and Glucose Clearance
Kimple, M. E., Joseph, J. W., Bailey, C. L., Fueger, P. T., Hendry, I. A., Newgard, C. B., & Casey, P. J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m706481200 · Cited by 51 · see citing works
Bassoni, D. L., Raab, W. J., Achacoso, P. L., Loh, C.-Y., & Wehrman, T. S. (2012) · Methods in molecular biology · doi:10.1007/978-1-61779-909-9_9 · Cited by 46 · see citing works
Constitutively active melatonin MT1 receptors in male rat caudal arteries
Erşahin, Ç. H., Masana, M. I., & Dubocovich, M. L. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01407-3 · Cited by 35 · see citing works
Clément, N., Renault, N., Guillaume, J., Cecon, E., Journé, A., Laurent, X., Tadagaki, K., Cogé, F., Gohier, A., Delagrange, P., et al. (2017) · British Journal of Pharmacology · doi:10.1111/bph.14029 · Cited by 34 · see citing works
Devavry, S., Legros, C., Brasseur, C., Delagrange, P., Spadoni, G., Cohen, W., Malpaux, B., Boutin, J. A., & Nosjean, O. (2011) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2011.00968.x · Cited by 22 · see citing works
Bonnefond, A., Karamitri, A., Jockers, R., & Froguel, P. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.08.015 · Cited by 18 · see citing works
Avancées dans la génétique de la glycémie à jeun
Bouatia‐Naji, N., Bonnefond, A., & Froguel, P. (2009) · médecine/sciences · doi:10.1051/medsci/20092511897 · Cited by 7 · see citing works
Sakurai, T., Koike, T., & Nakayama, M. (2014) · Pharmacology · doi:10.1159/000362561 · Cited by 7 · see citing works
Exon Sequencing of G Protein-Coupled Receptor Genes and Perspectives for Disease Treatment
Karamitri, A., & Jockers, R. (2013) · Methods in pharmacology and toxicology · doi:10.1007/978-1-62703-779-2_17 · Cited by 6 · see citing works
From Association to Function: MTNR1B
Bonnefond, A., & Lyssenko, V. (2016) · Springer eBooks · doi:10.1007/978-3-319-01574-3_19 · Cited by 2 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Mechanisms of signalling and biased agonism in G protein-coupled receptors
Wootten, D. L., Christopoulos, A., Martí-Solano, M., Babu, M. M., & Sexton, P. M. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0049-3 · Cited by 730 · see citing works
Melatonin in type 2 diabetes mellitus and obesity
Karamitri, A., & Jockers, R. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0130-1 · Cited by 268 · see citing works
Self-citationMelatonin effects on glucose metabolism: time to unlock the controversy
Garaulet, M., Qian, J., Florez, J. C., Arendt, J., Saxena, R., & Scheer, F. A. J. L. (2020) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2019.11.011 · Cited by 193 · see citing works
“Moreover, a genetic study together with a recent functional genomics study has reported that rare coding variants in the melatonin receptor gene MTNR1B, that inhibit melatonin binding or signaling, are collectively associated with increased risk of T2D [11, 12]; although recent well-powered analysis of coding variants…”
BackgroundMitochondria: the birth place, battle ground and the site of melatonin metabolism in cells
Tan, D.-X., & Reiter, R. J. (2019) · Melatonin Research · doi:10.32794/mr11250011 · Cited by 172 · see citing works
XFEL structures of the human MT2 melatonin receptor reveal the basis of subtype selectivity
Johansson, L. C., Stauch, B., McCorvy, J. D., Han, G. W., Patel, N., Huang, X., Batyuk, A., Gati, C., Slocum, S. T., Li, C., et al. (2019) · Nature · doi:10.1038/s41586-019-1144-0 · Cited by 153 · see citing works
“Subtype-selective compounds are desirable due to the involvement of MT 2 in T2D, where a number of single nucleotide polymorphisms (SNPs) have been reported 4,5 .”
Namkung, Y., Gouill, C. L., Kumar, S., Cao, Y., Teixeira, L. B., Lukasheva, V., Giubilaro, J., Simões, S. C., Longpré, J., Devost, D., et al. (2018) · Science Signaling · doi:10.1126/scisignal.aat1631 · Cited by 148 · see citing works
Melatonin Signaling a Key Regulator of Glucose Homeostasis and Energy Metabolism
Owino, S., Buonfiglio, D. D. C., Tchio, C. I. M., & Tosini, G. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00488 · Cited by 124 · see citing works
“In 2018, the same group under the lead of Karamitri reported their assessment of all forty variants on multiple pathways thought to be regulated by MTNR1B activation (58).”
BackgroundInfluentialThe role of melatonin in the treatment of type 2 diabetes mellitus and Alzheimer's disease
Shen, S., Liao, Q., Wong, Y. K., Chen, X., Yang, C., Xu, C., Sun, J., & Wang, J. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.66871 · Cited by 84 · see citing works
“It has been shown that disturbance of melatonin signaling is implicated in development of T2DM raised by IR [39-42].”
BackgroundBiased Signaling of the Mu Opioid Receptor Revealed in Native Neurons
Ehrlich, A. T., Semache, M., Gross, F., Fonte, D. F. D., Runtz, L., Colley, C., Mezni, A., Gouill, C. L., Lukasheva, V., Hogue, M., et al. (2019) · iScience · doi:10.1016/j.isci.2019.03.011 · Cited by 81 · see citing works
Garaulet, M., Lopez-Minguez, J., Dashti, H. S., Vetter, C., Hernández-Martínez, A. M., Pérez-Ayala, M., Baraza, J. C., Wang, W., Florez, J. C., Scheer, F. A. J. L., et al. (2022) · Diabetes Care · doi:10.2337/dc21-1314 · Cited by 77 · see citing works
Chemogenetics defines receptor-mediated functions of short chain free fatty acids
Bolognini, D., Barki, N., Butcher, A. J., Hudson, B. D., Sergeev, E., Molloy, C., Hodge, D., Bradley, S. J., Gouill, C. L., Bouvier, M., et al. (2019) · Nature Chemical Biology · doi:10.1038/s41589-019-0270-1 · Cited by 72 · see citing works
Translating biased signaling in the ghrelin receptor system into differential in vivo functions
Mende, F., Hundahl, C., Plouffe, B., Skov, L. J., Sivertsen, B., Madsen, A. N., Lückmann, M., Diep, T. A., Offermanns, S., Frimurer, T. M., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1804003115 · Cited by 64 · see citing works
“To measure the interaction between Gγ5 and GRK2 (using a GRK2-based BRET biosensor detecting G-protein activation), HEK293 cells were cotransfected with human GhrR, GRK2-GFP10, RlucII-Gγ5, or Gβ1 in the absence (control) or presence of the tested Gα subunit (48, 49).”
MethodCircadian Clocks Make Metabolism Run
Sinturel, F., Petrenko, V., & Dibner, C. (2020) · Journal of Molecular Biology · doi:10.1016/j.jmb.2020.01.018 · Cited by 64 · see citing works
Structural insights into melatonin receptors
Stauch, B., Johansson, L. C., & Cherezov, V. (2019) · FEBS Journal · doi:10.1111/febs.15128 · Cited by 61 · see citing works
Melatonin receptor structures shed new light on melatonin research
Cecon, E., Liu, L., & Jockers, R. (2019) · Journal of Pineal Research · doi:10.1111/jpi.12606 · Cited by 60 · see citing works
Gao, W., Liu, L., Huh, E., Gbahou, F., Cecon, E., Oshima, M., Houzé, L., Katsonis, P., Hegron, A., Fan, Z., et al. (2023) · Nature Metabolism · doi:10.1038/s42255-023-00889-6 · Cited by 56 · see citing works
Self-citationMelatonin receptor structure and signaling
Okamoto, H. H., Cecon, E., Nureki, O., Rivara, S., & Jockers, R. (2024) · Journal of Pineal Research · doi:10.1111/jpi.12952 · Cited by 56 · see citing works
“…[ 3 H]melatonin binding assays [91] Nano ‐ BRET ligand binding assay [92] GTP γ S 35 binding assay [93] BRET G protein activation assay [5, 6] ß ‐ arrestin recruitment assay [5, 94, 95] Internalization assay [96] cAMP assay [97] Impedance measurement [98] BRET receptor dimerization…”
MethodMelatonin MT1 and MT2 receptor ERK signaling is differentially dependent on Gi/o and Gq/11 proteins
Chen, M., Cecon, E., Karamitri, A., Gao, W., Gerbier, R., Ahmad, R., & Jockers, R. (2020) · Journal of Pineal Research · doi:10.1111/jpi.12641 · Cited by 53 · see citing works
Structure-based discovery of potent and selective melatonin receptor agonists
Patel, N., Huang, X., Grandner, J. M., Johansson, L. C., Stauch, B., McCorvy, J. D., Liu, Y., Roth, B. L., & Katritch, V. (2020) · eLife · doi:10.7554/elife.53779 · Cited by 48 · see citing works
“Moreover, MT2 single nucleotide polymorphisms (SNPs) are implicated in type-2 diabetes (Karamitri et al., 2018) (T2D), emphasizing the importance of MT receptors in a wide variety of functions relevant to human health and the quality of life (Karamitri and Jockers, 2019).”
BackgroundIlluminating the complexity of GPCR pathway selectivity – advances in biosensor development
Wright, S. C., & Bouvier, M. (2021) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2021.04.006 · Cited by 43 · see citing works
Buonfiglio, D. D. C., Tchio, C. I. M., Furigo, I. C., Donato, J., Baba, K., Cipolla‐Neto, J., & Tosini, G. (2019) · Journal of Pineal Research · doi:10.1111/jpi.12580 · Cited by 43 · see citing works
Conformation- and activation-based BRET sensors differentially report on GPCR–G protein coupling
Wright, S. C., Avet, C., Gaitonde, S. A., Arrate, I. M., Gouill, C. L., Hogue, M., Breton, B., Koutsilieri, S., Dı́ez-Alarcia, R., Héroux, M., et al. (2024) · Science Signaling · doi:10.1126/scisignal.adi4747 · Cited by 29 · see citing works
“Among them, assays were developed on the basis of the competition between modified versions of GPCR kinase-2 and - 3 (GRK2/3) and G α for binding to the released G βγ , by measuring BRET between GRK and G γ in the presence or absence of unmodified G α subunits ( 14 – 16 ).”
BackgroundGerbier, R., Ndiaye‐Lobry, D., de Morentin, P. B. M., Cecon, E., Heisler, L. K., Delagrange, P., Gbahou, F., & Jockers, R. (2020) · The FASEB Journal · doi:10.1096/fj.202000305r · Cited by 29 · see citing works
Anti-Inflammatory Effects of Melatonin in Rats with Induced Type 2 Diabetes Mellitus
Yapışlar, H., Hacıosmanoğlu, E., Sarıoğlu, T., Değirmencioğlu, S., Söğüt, İ., Poteser, M., & Ekmekçioğlu, C. (2022) · Life · doi:10.3390/life12040574 · Cited by 29 · see citing works
“After rats reached 200 g body weight T2DM was induced by intraperitoneal (i.p.) injection of 100 mg/kg NAD (nicotinamide adenine dinucleotide) and 50 mg/kg STZ (streptozotocin) Life 2022, 12, 574 3 of 18 respectively.”
BackgroundInfluentialSomalo-Barranco, G., Zottola, A. C. P., Abdulrahman, A. O., Zein, R. M. E., Cannich, A., Muñoz, L., Serra, C., Oishi, A., Marsicano, G., Masri, B., et al. (2023) · Cell chemical biology · doi:10.1016/j.chembiol.2023.07.009 · Cited by 22 · see citing works
Melatonin Potentiates the Therapeutic Effects of Metformin in Women with Metabolic Syndrome
Abood, S. J., Abdulsahib, W. K., Hussain, S. A., & Ismail, S. H. (2020) · Scientia Pharmaceutica · doi:10.3390/scipharm88020028 · Cited by 22 · see citing works
“Melatonin encourages the activation of the insulin receptor β-subunit tyrosine kinase and fast MT1/MT2 membrane receptor-dependent tyrosine phosphorylation [11].”
BackgroundWang, J., Zhu, T., Ma, X., Wang, Y., Liu, J., Li, G., Liu, Y., Ji, P., Zhang, Z., Zhang, L., et al. (2020) · Biology of Reproduction · doi:10.1093/biolre/ioaa190 · Cited by 21 · see citing works
“As to the glucose metabolism, MT2 KO downregulated insulin signaling and MT2 SNP increases the risk of type 2 diabetes [26, 78].”
Journal of pineal research guideline for authors: Defining and characterizing melatonin targets
Cecon, E., Legros, C., Boutin, J. A., & Jockers, R. (2020) · Journal of Pineal Research · doi:10.1111/jpi.12712 · Cited by 17 · see citing works
Human physiology of genetic defects causing beta-cell dysfunction.
Kettunen, J., & Tuomi, T. (2020) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.12.038 · Cited by 17 · see citing works
Noseda, A. C. D., Rodrigues, L. S., Targa, A., Ilkiw, J. L., Fagotti, J., dos Santos, P. D., Cecon, E., Markus, R. P., Solimena, M., Jockers, R., et al. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173722 · Cited by 16 · see citing works
Theofilis, P., Vordoni, A., & Kalaitzidis, R. (2022) · American Journal of Nephrology · doi:10.1159/000525441 · Cited by 15 · see citing works
Melatonin protects against oxybenzone-induced deterioration of mouse oocytes during maturation
Jin, L. G., Zhu, H., Kang, X., Lin, L., Zhang, P.-Y., Tan, T., Yu, Y., & Fan, Y. (2020) · Aging · doi:10.18632/aging.202323 · Cited by 15 · see citing works
“It is noteworthy that MT2 mutation is associated with increased type 2 diabetes risk and obese [61, 62].”
Meulebrouck, S., Merrheim, J., Quéniat, G., Bourouh, C., Derhourhi, M., Boissel, M., Yi, X., Badreddine, A., Boutry, R., Leloire, A., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-51004-6 · Cited by 15 · see citing works
Melatonin and its Relationships with Diabetes and Obesity: A Literature Review
Ramirez, A. V. G., Filho, D. R., & de Sá, L. B. P. C. (2020) · Current Diabetes Reviews · doi:10.2174/1573399816666200727102357 · Cited by 13 · see citing works
Molecular Characterization and Pharmacology of Melatonin Receptors in Animals
Cecon, E., Boutin, J. A., & Jockers, R. (2023) · Receptors · doi:10.3390/receptors2020008 · Cited by 12 · see citing works
“For MT1, additional coupling to G12 and G15 was observed [103,104].”
BackgroundImam, A., Winnebeck, E. C., Buchholz, N., Froguel, P., Bonnefond, A., Solimena, M., Ivanova, A., Bouvier, M., Plouffe, B., Charpentier, G., et al. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.564140 · Cited by 12 · see citing works
Investigating G-protein coupled receptor signalling with light-emitting biosensors
Demby, A., & Zaccolo, M. (2024) · Frontiers in Physiology · doi:10.3389/fphys.2023.1310197 · Cited by 11 · see citing works
Modeling the Heterodimer Interfaces of Melatonin Receptors
Tse, L. H., & Wong, Y. H. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.725296 · Cited by 11 · see citing works
“However, the spontaneous β-arrestin 2 recruitment and Gi1 activation were similar to that of wild-type MT2 (Karamitri et al., 2018).”
BackgroundInfluentialMonoamines' role in islet cell function and type 2 diabetes risk
Roberts, F. L., Cataldo, L. R., & Fex, M. (2023) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2023.08.009 · Cited by 11 · see citing works
Hégron, A., Huh, E., Deupí, X., Sokrat, B., Gao, W., Gouill, C. L., Canouil, M., Boissel, M., Charpentier, G., Roussel, R., et al. (2021) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.1c00157 · Cited by 11 · see citing works
Biased signaling in drug discovery and precision medicine
Ji, R., & Tao, Y. (2025) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2025.108804 · Cited by 9 · see citing works
Ackr3-Venus knock-in mouse lights up brain vasculature
Ehrlich, A. T., Semache, M., Couvineau, P., Wojcik, S., Kobayashi, H., Thelen, M., Gross, F., Hogue, M., Gouill, C. L., Darcq, E., et al. (2021) · Molecular Brain · doi:10.1186/s13041-021-00862-y · Cited by 9 · see citing works
Functional Investigation of Melatonin Receptor Activation by Homogenous cAMP Assay
Cecon, E., Guillaume, J., & Jockers, R. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2593-4_22 · Cited by 8 · see citing works
Labani, N., Gbahou, F., Noblet, M., Masri, B., Broussaud, O., Liu, J., & Jockers, R. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15071845 · Cited by 7 · see citing works
“The PathHunter assay from the DiscoverX company was used as described [33] to measure the recruitment of β-arrestin2 to melatonin receptors (DiscoverX/Eurofins).”
MethodPharmacology of Melatonin and Its Receptors
Singh, S., Rana, A., Kaur, S., Singh, J., Rahi, V., Choudhury, H., & Kumar, P. (2020) · Springer eBooks · doi:10.1007/978-981-15-3556-7_9 · Cited by 6 · see citing works
Pharmacogenomics of GPCR genes in type 2 diabetes and obesity
Gao, W., & Jockers, R. (2020) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2020.11.008 · Cited by 6 · see citing works
Tchio, C. I. M., Musani, S. K., Quarshie, A., & Tosini, G. (2021) · BMC Medical Genomics · doi:10.1186/s12920-021-00983-2 · Cited by 6 · see citing works
G Protein-Coupled Receptors and the Rise of Type 2 Diabetes in Children
Dallatana, A., Cremonesi, L., Trombetta, M., Fracasso, G., Nocini, R., Giacomello, L., & Innamorati, G. (2023) · Biomedicines · doi:10.3390/biomedicines11061576 · Cited by 6 · see citing works
“Direct investigation of 40 type 2 diabetes-associated variants of the MT2 receptor revealed that mutations determining a bias towards arrestin 3 recruitment, rather than Gαi/o, have the most statistically significant associations with increased type 2 diabetes risk [93].”
BackgroundWiechmann, A. F., Martin, T., & Horb, M. E. (2020) · Scientific Reports · doi:10.1038/s41598-020-70735-2 · Cited by 5 · see citing works
Plouffe, B., Karamitri, A., Flock, T., Gallion, J. M., Houston, S., Daly, C. A., Bonnefond, A., Guillaume, J., Gouill, C. L., Froguel, P., et al. (2022) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.1c00239 · Cited by 4 · see citing works
Wilkinson, J. C., Lehmler, H., & Roman, D. L. (2024) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.3c00388 · Cited by 4 · see citing works
Analyse approfondie du lien entre le récepteur MT2 de la mélatonine et le diabète de type 2
Hégron, A., & Jockers, R. (2019) · médecine/sciences · doi:10.1051/medsci/2019088 · Cited by 3 · see citing works
Melatonin and glucose metabolism.
Watanabe, K., Katagiri, S., & Hattori, A. (2020) · doi:10.24659/gsr.7.1_105 · Cited by 3 · see citing works
Goyal, V., & Tosini, G. (2024) · Journal of Pineal Research · doi:10.1111/jpi.70007 · Cited by 1 · see citing works
Tecucianu, R., Tunaru, S., & Petrescu, S. M. (2026) · Diabetology · doi:10.3390/diabetology7040068 · Cited by 1 · see citing works
Normand, C., Breton, B., Salze, M., Barbeau, E., Mancini, A. D., & Audet, M. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.175043 · Cited by 1 · see citing works
Nutrition, Epigenetics, and Circadian Rhythms
Cai, D., Liu, H., Li, K., & Zhu, Y. (2024) · Epigenetics and human health · doi:10.1007/978-3-031-54215-2_8 · Cited by 1 · see citing works
Impact of Melatonin on Brain Metabolism in Diabetes: A Narrative Review
Nwaji, A. R., Bisong, S. A., Antai, A. B., Okakpu, C. M., Okechukwu, M. P., Igwe, E. O., Okafor, C., Odoh, P. C., Chukwu, M. C., Esinulo, J. I., et al. (2025) · Natural Product Communications · doi:10.1177/1934578x251340772 · Cited by 2 · see citing works
“…nighttime melatonin levels seen in T2DM patients 74 and the numerous rare MT 2 mutants that cause a loss-of-function phenotype and are linked to an increased risk of developing T2DM, 74,95 suggest rather the opposite, namely that dampening of the melatonin system results in the development of T2DM.”
Bockaert, J. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.735418905.793559380
Sørensen, K. V., Justesen, J. M., Ängquist, L. H., Bork‐Jensen, J., Hartmann, B., Jørgensen, N. R., Rungby, J., Sørensen, H. T., Vaag, A. A., Nielsen, J. S., et al. (2025) · Diabetologia · doi:10.1007/s00125-025-06381-y
“Despite elevated cell surface expression, previous studies [13, 14, 38] found no evidence of enhanced signalling to explain this opposing effect direction.”
Wen, Y.-L., Huang, Y.-C., Liao, C.-C., Kao, S., Pan, K., Yang, H.-W., To, S.-Y., Yeh, C. B., & Kao, L. (2026) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-026-02130-2
Identification of Melatonin-like activities in plant extracts
Labani, N. (2021) · theses.fr (ABES) · doi:10.70675/495441a7z7c22z4734za4fdzc81458e209ef
- Authors
- Karamitri, A., Plouffe, B., Bonnefond, A., Chen, M., Gallion, J., Guillaume, J.-L., Hegron, A., Boissel, M., Canouil, M., Langenberg, C., Wareham, N. J., Le Gouill, C., Lukasheva, V., Lichtarge, O., Froguel, P., Bouvier, M., & Jockers, R.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Institute for Research in Immunology and Cancer (CA)
- Baylor College of Medicine (US)
- Inserm, U1016, Institut Cochin, Paris, France.
- University of Cambridge (GB)
- Institute for Research in Immunology and Cancer and Department of Biochemistry and Molecular Medicine, Université de Montréal, Montreal, Québec H3C 3J7, Canada.
- Corresponding author
- Karamitri, Angeliki
- Plouffe, Bianca
- Bonnefond, Amélie
- Froguel, Philippe
- Bouvier, Michel
- Jockers, Ralf
- ORCID
- Venue
- Science Signaling
- Published
- 2018-08-28
- Volume
- 11
- Issue
- 545
- ISSN
- 1937-9145 (ISSN-L)
- 1945-0877
- OpenAlex
- W2888988036
- Cited by
- 62
- References
- 70
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 7 · 2023: 6 · 2022: 7 · 2021: 6 · 2020: 18 · 2019: 9 · 2018: 4
- FWCI
- 5.20
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science Signaling (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Research Portal (Queen's University Belfast) (submittedVersion)
- Funders
- Canadian Institutes of Health Research (MOP10501)
- Agence Nationale de la Recherche (ANR-2011-BSV1-012-01 “MLT2D”, ANR-2011-META “MELA-BETES”, ANR-12-RPIB-0016 “MED-HET-REC-2”)
- Fondation de la Recherche Médicale (Equipe FRM DEQ20130326503)
- “Who am I?” laboratory of excellence (ANR-11-LABX-0071)
- Topics
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Circadian rhythm and melatonin
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- type 2 diabetes, MT2 receptor, receptor isoforms, receptor signaling, melatonin
- MeSH terms
- beta-Arrestin 2, Antioxidants, Diabetes Mellitus, Type 2, Humans, Melatonin, Phosphorylation, Genetic Variation, Signal Transduction, Receptor, Melatonin, MT2, Extracellular Signal-Regulated MAP Kinases, HEK293 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review